Figure 4. Tumor responders to IBT had a significantly better 5-year recurrence-free survival probability (90%) than patients without tumor response to IBT (21%; P<0.001).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.